Profitelligence Profitelligence · Filing Ledger Search all insiders →

Entity Profile · SEC Form 4 Activity · Trailing 90 Days

Catalyst4, Inc.

Over the trailing 90 days, Catalyst4, Inc. (a reporting holder of MapLight Therapeutics, Inc.) bought $15.3M of stock in MLPT, per 4 SEC Form 4 transactions.

Role
Reporting holder
Companies
MLPT
Window
Trailing 90 days · 4 transactions · CIK 1900201
Net activity
+$15.3M ($15.3M bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
MLPTMapLight Therapeutics, Inc.4$15.3M$15.3M

Transactions (4)

DateSymbolTypeSharesValueDescription
2026-07-30MLPTBuy1.0M$13.0MOpen market or private purchase
2026-07-29MLPTBuy3.0K$38KOpen market or private purchase
2026-07-28MLPTBuy141.1K$1.5MOpen market or private purchase
2026-07-28MLPTBuy65.1K$761KOpen market or private purchase

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Catalyst4, Inc.

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free